鎮痛剤の世界市場レポート 2025

鎮痛剤の市場規模は、今後数年間で安定した成長が見込まれます。2029年には年間平均成長率（CAGR）3.2％で1,294億6,000万米ドルに成長します。予測期間の成長は、疼痛管理の代替、市場競争、消費者の健康意識、人口動態の変化、慢性疾患の増加に起因すると考えられます。予測期間の主な動向には、個別化医療、非オピオイド代替薬、CBDとカンナビノイドの使用、標的疼痛管理、入手しやすさ、手頃な価格などがあります。

鎮痛剤市場は、慢性疾患の顕著な増加に牽引され、大きな成長を遂げています。慢性疾患は非感染性疾患（NCD）としても知られ、遺伝的、生理的、環境的、行動的な要因が組み合わさって長期にわたって発症します。世界保健機関（WHO）が2022年9月に発表した報告書によると、NCDは世界の死亡者数の74％を占め、年間4,100万人が死亡しています。これらの疾患により、70歳までに毎年1,700万人が早死にし、その86％が低・中所得国で発生しています。慢性疾患の蔓延が拡大していることは、鎮痛剤市場の拡大を後押しする重要な要因です。

ヘルスケア支出の増加は、今後の鎮痛剤市場の成長を促進すると予測されています。ヘルスケア支出には、保健サービス、家族計画、栄養プログラム、健康を中心とした緊急支援などの提供に関連するすべての費用が含まれます。ヘルスケア支出の増加は、新しい鎮痛薬や強化された鎮痛薬を生み出すための製薬業界の研究開発を支えています。例えば、2024年5月、英国政府機関である国家統計局は、2022年から2023年にかけて総ヘルスケア支出が名目ベースで5.6％増加したと報告しました。その結果、医療費の増加が鎮痛剤市場の成長に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界鎮痛剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の鎮痛剤市場：成長率分析
• 世界の鎮痛剤市場の実績：規模と成長, 2019-2024
• 世界の鎮痛剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界鎮痛剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の鎮痛剤市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非オピオイド
• オピオイド
• 世界の鎮痛剤市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• ドラッグストア
• 世界の鎮痛剤市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 内部鎮痛剤
• 外部鎮痛剤
• 世界の鎮痛剤市場、非オピオイドのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非ステロイド性抗炎症薬（NSAID）
• アセトアミノフェン（パラセタモール）
• サリチル酸塩
• 世界の鎮痛剤市場、オピオイドの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 天然オピオイド
• 半合成オピオイド
• 合成オピオイド

第7章 地域別・国別分析

• 世界の鎮痛剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の鎮痛剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 鎮痛剤市場：競合情勢
• 鎮痛剤市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Medley Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer HealthCare Pharmaceuticals LLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis International AG
• Sanofi SA
• Bristol-Myers Squibb Co.
• AstraZeneca Plc.
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical company Limited
• Eli Lilly and Company
• Reckitt Benckiser Group plc
• Viatris Inc.
• Teva Pharmaceuticals Industries Ltd.
• Sun Pharmaceutical Industries Limited
• Purdue Pharma L.P
• Cipla Limited
• Allergan Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 鎮痛剤市場2029：新たな機会を提供する国
• 鎮痛剤市場2029：新たな機会を提供するセグメント
• 鎮痛剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Analgesics are medications used to alleviate pain, including conditions such as musculoskeletal pain, surgical pain, trauma-induced pain, and cancer-related pain. Examples of analgesics include codeine, hydrocodone, oxycodone, and methadone.

The main types of analgesics are non-opioids and opioids. Non-opioid analgesics are pain relievers available over-the-counter (OTC) and by prescription. They are increasingly promoted as a desirable, safe, and effective first-line therapeutic option in various clinical settings for managing mild to severe acute and chronic pain. Analgesics come in different forms, including prescription analgesics and over-the-counter (OTC) analgesics, with various routes of administration such as oral, intravenous, rectal, transdermal, and topical. They are used both internally (internal analgesics) and externally (external analgesics) and are distributed through channels such as hospital pharmacies, retail pharmacies, and drug stores.

The analgesics market research report is one of a series of new reports from The Business Research Company that provides analgesics market statistics, including analgesics industry global market size, regional shares, competitors with an analgesics market share, detailed analgesics market segments, market trends, and opportunities, and any further data you may need to thrive in the analgesics industry. This analgesics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The analgesics market size has grown steadily in recent years. It will grow from $109.97 billion in 2024 to $113.96 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to alternative therapies impact, safety and efficacy studies, pain prevalence, marketing and promotion, economic factors.

The analgesics market size is expected to see steady growth in the next few years. It will grow to $129.46 billion in 2029 at a compound annual growth rate (CAGR) of 3.2%. The growth in the forecast period can be attributed to pain management alternatives, market competition, consumer health awareness, demographic shifts, rising chronic diseases. Major trends in the forecast period include personalized medicine, non-opioid alternatives, CBD and cannabinoids usage, targeted pain management, accessibility and affordability.

The analgesics market is experiencing significant growth, driven by a notable increase in the prevalence of chronic diseases. Chronic diseases, also known as noncommunicable diseases (NCDs), develop over an extended period due to a combination of genetic, physiological, environmental, and behavioral factors. According to a September 2022 report from the World Health Organization (WHO), NCDs account for 74% of global fatalities, totaling 41 million deaths annually. These diseases result in 17 million premature deaths each year before the age of 70, with 86% occurring in low- and middle-income nations. The escalating prevalence of chronic diseases is a key factor fueling the expansion of the analgesics market as these drugs effectively treat and alleviate severe pain associated with various medical conditions.

The increase in healthcare expenditures is anticipated to drive the growth of the analgesics market in the future. Healthcare expenditures encompass all costs related to providing health services, family planning, nutrition programs, and emergency assistance with a health focus. Rising healthcare spending supports research and development within the pharmaceutical industry for the creation of new and enhanced analgesic medications. For example, in May 2024, the Office for National Statistics, a UK government department, reported that total healthcare spending increased by 5.6% in nominal terms from 2022 to 2023. Consequently, the rise in healthcare expenditures is fueling the growth of the analgesics market.

Companies in the analgesics market are strategically investing to foster growth. Leading manufacturers are channeling investments into clinical-stage companies to enhance their market position and gain a competitive edge. In January 2022, Concentric Analgesics, Inc., secured $20 million in convertible note financing to advance the Phase 3 development of Vocacapsaicin, its lead product candidate for post-surgical pain. Such investments allow companies to expand geographically and attain specialized expertise in research and development, strengthening their overall competitiveness.

Leading companies in the analgesic market are increasingly concentrating on introducing combination analgesics to strengthen their competitive position. Combination analgesics contain a blend of two or more pain-relieving (analgesic) drugs, often designed to provide enhanced pain relief by targeting pain through multiple mechanisms. For instance, in February 2024, UK-based Hikma Pharmaceuticals plc launched COMBOGESIC IV (acetaminophen and ibuprofen) in the United States. This intravenous formulation combines acetaminophen (paracetamol) and ibuprofen, offering dual-action pain relief through the analgesic and anti-inflammatory properties of both drugs. Developed as a non-opioid alternative for pain management, COMBOGESIC IV delivers 1,000 mg of acetaminophen and 300 mg of ibuprofen, providing an effective option amid rising opioid concerns. This formulation offers over twice the pain relief of each component alone, with a quicker onset and a favorable safety profile.

In December 2023, Wellnex Life Limited, an Australian company in the health and wellness sector, acquired Pain Away Ltd. for $22 million. This acquisition aligns with Wellnex's long-term strategy to own brands in stable healthcare segments, strengthening its market position. Pain Away Ltd., a U.S.-based company, specializes in developing and distributing topical pain relief products.

Major companies operating in the analgesics market include Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC

North America was the largest region in the analgesics market in 2024. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the analgesics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The analgesics market consists of sales of codeine, hydrocodone, oxycodone, and methadone. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Analgesics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on analgesics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for analgesics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The analgesics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Non-opioids; Opioids
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drug Stores
• 3) By Application: Internal Analgesics; External Analgesics
• Subsegments:
• 1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Acetaminophen (Paracetamol); Salicylates
• 2) By Opioids: Natural Opioids; Semi-Synthetic Opioids; Synthetic Opioids
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Medley Pharmaceuticals Limited; AbbVie Inc.; Bayer HealthCare Pharmaceuticals LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Analgesics Market Characteristics

3. Analgesics Market Trends And Strategies

4. Analgesics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Analgesics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Analgesics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Analgesics Market Growth Rate Analysis
• 5.4. Global Analgesics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Analgesics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Analgesics Total Addressable Market (TAM)

6. Analgesics Market Segmentation

• 6.1. Global Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-opioids
• Opioids
• 6.2. Global Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• 6.3. Global Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Internal Analgesics
• External Analgesics
• 6.4. Global Analgesics Market, Sub-Segmentation Of Non-Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Acetaminophen (Paracetamol)
• Salicylates
• 6.5. Global Analgesics Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Opioids
• Semi-Synthetic Opioids
• Synthetic Opioids

7. Analgesics Market Regional And Country Analysis

• 7.1. Global Analgesics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Analgesics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Analgesics Market

• 8.1. Asia-Pacific Analgesics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Analgesics Market

• 9.1. China Analgesics Market Overview
• 9.2. China Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Analgesics Market

• 10.1. India Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Analgesics Market

• 11.1. Japan Analgesics Market Overview
• 11.2. Japan Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Analgesics Market

• 12.1. Australia Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Analgesics Market

• 13.1. Indonesia Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Analgesics Market

• 14.1. South Korea Analgesics Market Overview
• 14.2. South Korea Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Analgesics Market

• 15.1. Western Europe Analgesics Market Overview
• 15.2. Western Europe Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Analgesics Market

• 16.1. UK Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Analgesics Market

• 17.1. Germany Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Analgesics Market

• 18.1. France Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Analgesics Market

• 19.1. Italy Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Analgesics Market

• 20.1. Spain Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Analgesics Market

• 21.1. Eastern Europe Analgesics Market Overview
• 21.2. Eastern Europe Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Analgesics Market

• 22.1. Russia Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Analgesics Market

• 23.1. North America Analgesics Market Overview
• 23.2. North America Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Analgesics Market

• 24.1. USA Analgesics Market Overview
• 24.2. USA Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Analgesics Market

• 25.1. Canada Analgesics Market Overview
• 25.2. Canada Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Analgesics Market

• 26.1. South America Analgesics Market Overview
• 26.2. South America Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Analgesics Market

• 27.1. Brazil Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Analgesics Market

• 28.1. Middle East Analgesics Market Overview
• 28.2. Middle East Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Analgesics Market

• 29.1. Africa Analgesics Market Overview
• 29.2. Africa Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Analgesics Market Competitive Landscape And Company Profiles

• 30.1. Analgesics Market Competitive Landscape
• 30.2. Analgesics Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medley Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer HealthCare Pharmaceuticals LLC Overview, Products and Services, Strategy and Financial Analysis

31. Analgesics Market Other Major And Innovative Companies

• 31.1. Novartis International AG
• 31.2. Sanofi SA
• 31.3. Bristol-Myers Squibb Co.
• 31.4. AstraZeneca Plc.
• 31.5. Abbott Laboratories
• 31.6. GlaxoSmithKline plc
• 31.7. Takeda Pharmaceutical company Limited
• 31.8. Eli Lilly and Company
• 31.9. Reckitt Benckiser Group plc
• 31.10. Viatris Inc.
• 31.11. Teva Pharmaceuticals Industries Ltd.
• 31.12. Sun Pharmaceutical Industries Limited
• 31.13. Purdue Pharma L.P
• 31.14. Cipla Limited
• 31.15. Allergan Inc.

32. Global Analgesics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Analgesics Market

34. Recent Developments In The Analgesics Market

35. Analgesics Market High Potential Countries, Segments and Strategies

• 35.1 Analgesics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Analgesics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Analgesics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer